Immune Cells Kill Foes By Disrupting Mitochondria 2 Ways 5/16/2008 - When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. A new study shows T cells ... Source: Harvard Medical School
	5/16/2008 Why Weight Loss Supplements Don't Work, According To GSK A petition seeking to classify all weight loss claims as drug claims highli... Source: NutraIngredients-USA
	5/16/2008 Redesigned Scienceware Separatory Funnel Rack The ultimate in flexibility, the new Scienceware Separatory Funnel Rack all... Source: Bel-Art Products, Inc.
	5/16/2008 Biacore Q100 - A Rapid And Reliable New-Generation System Platform Enabling High-Throughput, Serological Screening For Pathogens. GE Healthcare today announced the introduction of Biacore™ Q100, a new-gene... Source: GE Healthcare
	5/16/2008 New Adaptive Robotic Liquid Pipettor From Hudson Control Group Hudson Control Group recently announced they have added new features to the... Source: Hudson Control Group
	5/16/2008 Novagen® KOD Xtreme™ Hot Start DNA Polymerase To address the needs of scientists working with challenging PCR targets, EM... Source: EMD Chemicals
	5/16/2008 Drug Therapy To Bolster Immune System Cells Found Effective Toward Childhood Cancer Researchers from The University of Texas M. D. Anderson Cancer Center have ... Source: University of Texas M. D. Anderson Cancer Center
	5/16/2008 Carnegie Mellon Scientists Unveil New Tool To Understand Evolution Of Multi-Domain Genes Carnegie Mellon scientists have discovered critical flaws in the standard m... Source: Carnegie Mellon University
	More Breaking News

	5/14/2008 Novosom Granted US and European Patents for RNAi-Delivering Smarticles® Source: Novosom AG
	4/24/2008 Invention Gives Improved Gene Technology Analysis Source: Norwegian Institute of Public Health
	4/18/2008 Federal Court in Canada Upholds Pfizer’s Norvasc Patent Source: BUSINESS WIRE
	More Patent News

	5/16/2008 Avastin Improves Brain Cancer Survival Source: Reuters
	5/15/2008 Ambrilia Biopharma Announces Positive Phase III Results - Octreotide C2L Source: Ambrilia Biopharma Inc.
	5/14/2008 Opexa Therapeutics Reports First Quarter 2008 Financial Results and Updates on Tovaxin® Phase IIb Study Source: BUSINESS WIRE
	More Clinical Trials News

Specialized Search Tools:
Antibodies | Protein and Peptide | Chromatography and Columns | Vectors | CPG & Phosphormaidites | Biomolecules

Molecular Biology | Lab Equipment | Tissue Culture | Cell Biology | Bio Services | Protein Biochemistry
Immunochemicals | Antibody Search | Browse Antibodies | Software | Microarrays

Product Reviews | News | Protocols | Life Science Forums | Product Centers | 
New Technology | Promotions | Videos | Resources | Articles

VISIT OUR SISTER SITES:
Searching for medical products? Visit Medcompare.com   |   Searching for dental products? Visit Dentalcompare.com